Neutrophils in cancer: prognostic role and therapeutic strategies.
Ocana A, Nieto-Jiménez C, Pandiella A, Templeton AJ. · 2017
Read Neutrophils in cancer: prognostic role and therapeutic strategies. by Ocana A, Nieto-Jiménez C, Pandiella A, Templeton AJ. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5558711.txt.
Description
Ocana and co-authors present a review in Molecular Cancer on neutrophils in cancer. Neutrophils are the most common white blood cells. High levels of them inside tumors link to worse outcomes in many solid cancers. The authors ask why, and how doctors might use that fact.
Neutrophils can aid tumor growth, spread, and new blood vessel growth. Simple blood measures, such as the neutrophil-to-lymphocyte ratio, may help predict a patient's course. The review also covers drugs that aim to cut neutrophil numbers or block their move into tumors. Early models support some of these tactics. Readers get a compact guide to an immune cell now seen as a cancer target.
Catalog record
| CREATOR | Ocana A, Nieto-Jiménez C, Pandiella A, Templeton AJ. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |